Clinical Trial Update: Topical Alprostadil for Female Sexual Arousal Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topical alprostadil for female sexual arousal disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Female Sexual Arousal Disorder
• Sexual Dysfunction

Drugs mentioned

• Alprostadil (topical) (alprostadil)

Snippet

Sponsor: VIVUS LLC | Conditions: Sexual Dysfunction, Physiological | Phase 2 | Status: COMPLETED